David Haen

What investor doesn't want to own a solid company with exciting prospects for business growth in the near- and mid-term? Healthcare stocks often provide a safe haven during uncertain market conditions. Here we explore a few interesting opportunities ranging from a big pharma name to a pre-revenue biotech. Image Source: Getty Images. 1. Merck If you want a solid stock that allows you to sleep soundly at night, buy Merck (NYSE: MRK).

Developing novel drugs for unmet medical needs remains the mission for many emerging drug developers. These pharma companies tackle a range of diseases but have one common attribute. Healthcare investors can look past the development risk. Two companies have approved drugs recently launched into the market, and the third aims to join those ranks next year. 1.

The sheer volume of biotech IPOs over the past few years makes it challenging to keep up to date on all these newly public companies. Several have returned to the capital markets to load up on cash to fund ongoing research and development (R&D) efforts. Among this crowd, Y-mAbs Therapeutics (NASDAQ: YMAB) continues to execute as its stock price climbs. More than a unique name Y-mAbs refers to the company's research efforts on monoclonal antibodies, often referred to as mAbs.